1Go AS,Mozaffarian D,Roger VL,et al.Heart disease and stroke statistics--2014 update:a report from the American Heart Association[J].Circulation,2014,129:28-292.
2Copin JC,Gasche Y.Effect of the duration of middle cerebral artery occlusion on the risk of Hemorrhagic transformation after tissue plasminogen activator injection in rats[J].Brain Res,2008,1243:161-166.
3Winkler EA,Bell RD,Zlokovic BV.Central nervous system pericytes in health and disease[J].Nat Neurosci,2011,14(11):1398-1405.
4Armulik A,GenovéG.Pericytes regulate the bloodbrain barrier[J].Nature,2010,468(7323):557-561.
5Toth P,Tucsek Z,Sosnowska D,et al.Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension[J].J Cereb Blood Flow Metab,2013,33(11):1732-1742.
6Lo EH,Broderick JP,Moskowitz MA.tPA and proteolysis in the neurovascular unit[J].Stroke,2004,35(2):354-356.
7Won S,Lee JH,Wali B,et al.Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats:involvement of the VEGF-MMP pathway[J].J Cereb Blood Flow Metab,2014,34(1):72-80.
9Carbone F,Vuilleumier N,Bertolotto M,et al.Treatment with recombinant tissue plasminogen activator(r-TPA)induces neutrophil degranulation in vitro via defined pathways[J].Vascul Pharmacol,2015,64:16-27.
10Kono S,Deguchi K,Omote Y,et al.Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat[J].J Neurosci Res,2014,92(1):46-53.
